THERAPEUTIC BATH SALTS

Brand Owner (click to sort) Address Description
COSSET COSSET INC. 2451 South 600 West, Ste. 300 Salt Lake City UT 84115 Therapeutic bath salts, bath powders, aromatherapy bath marbles, and bath preparations for medical use; therapeutic soaps, face and body scrubs, face and body lotions, face and body moisturizers, face and body butters, face and body creams, face and body exfoliates, facial washes, facial masks, and lip balms, all for medical purposes;
NORDICTRACK ICON IP, INC. 1500 South 1000 West Logan UT 84321 Therapeutic bath salts, Aloe Vera gels, medicated body and lip balms, medicated foot creams, antibacterial sanitizing hand gels and medicated muscle creams and rubs;Beauty products, namely, thigh and body toning creams, aromatherapy bath and body massage oils, Aloe Vera gels, body moisturizers and lotions, body balms, body lotions, breast firming lotion, anti-wrinkle creams, foot creams, essential body oils, mineral bath preparations, bath salts, varicose vein lotions, vitamin complex creams and lotions, hand salves and lotions and facial cleansers, toothpaste, shampoo, pumice stones, lip balms, scent-ball diffusers, car scent diffusers, pumice stones, baby lotions, creams, ointments and soaps;NORDIC TRACK;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Tetrapeptide L-alanyl-L-glutamyl-L-asparagyl-L-proline of the general formula L-Ala-L-Glu-Asp-L-Pro is proposed as a biologically active compound stimulating the functional activity of neurones. The application of L-Ala-L-Glu-L-Asp-L-Pro tetrapeptide in medicine is proposed for the preparation of a drug stimulating the functional activity of neurones. There is proposed a pharmacological agent, which contains as its active base an effective amount of L-Ala-L-Glu-L-Asp-L-Pro tetrapeptide for its salts of the amino acid group (acetate, hydrochloride, oxalate) or its salts of carboxyl groups (the salts of sodium, potassium, calcium, lithium, zinc, magnesium, and also the salts of organic and inorganic cations-ammonium, triethylammonium). The agent is proposed for parenteral, intranasal and oral administration. In accordance with the invention, the method of stimulating the functional activity of neurones consists in preventive and/or therapeutic administration to the patient of the pharmacological agent in doses 0.01 to 100 ?g/kg of the body weight at least one a day for a period necessary for attaining a therapeutic effect.